Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both the weekly and monthly charts, and Bollinger Bands also indicate bullish momentum on both time frames. Daily moving averages are bullish as well. However, the KST shows a mildly bearish signal on the weekly and monthly, and Dow Theory presents a mixed view with a mildly bearish weekly signal but a mildly bullish monthly signal.
In terms of performance, Neurocrine has outperformed the S&P 500 over the past week and year, with returns of 2.79% compared to 1.92% for the S&P 500 in the last week, and 24.65% versus 16.90% over the past year. However, it has underperformed over longer periods, particularly in the 3-year and 5-year comparisons. Overall, the bullish indicators suggest a positive outlook in the near term.